Wireva

Experimental drug combo shrinks pancreatic tumors in most patients in early trial

An experimental daily pill paired with standard chemotherapy shrank tumors or halted their growth in most patients with advanced pancreatic cancer in early clinical trial results presented in Barcelona.

This item was produced with AI assistance under the editorial responsibility of Haydamax OÜ.

Monitoring item. The full text is not distributed. Extract and source below.

An experimental daily pill paired with standard chemotherapy shrank tumors or halted their growth in most patients with advanced pancreatic cancer in early clinical trial results presented in Barcelona.

Same event, other desks

Story file →